RIM
ALXN

Redpoint Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Redpoint Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,684
Closed -$1.23M – 682
2021
Q2 		$1.23M Hold
6,684
– – 0.1% 241
2021
Q1 		$1.02M Hold
6,684
– – 0.09% 269
2020
Q4 		$1.04M Hold
6,684
– – 0.11% 213
2020
Q3 		$765K Sell
6,684
-13,307
-67% -$1.44M 0.08% 261
2020
Q2 		$2.24M Sell
19,991
-1,411
-7% -$150K 0.12% 193
2020
Q1 		$1.92M Hold
21,402
– – 0.12% 204
2019
Q4 		$2.31M Hold
21,402
– – 0.11% 231
2019
Q3 		$2.1M Buy
21,402
+437
+2% +$49.3K 0.11% 230
2019
Q2 		$2.75M Sell
20,965
-634
-3% -$81.7K 0.15% 181
2019
Q1 		$2.92M Buy
21,599
+9,028
+72% +$1.12M 0.15% 178
2018
Q4 		$1.22M Hold
12,571
– – 0.07% 321
2018
Q3 		$1.75M Hold
12,571
– – 0.09% 277
2018
Q2 		$1.56M Hold
12,571
– – 0.08% 290
2018
Q1 		$1.4M Hold
12,571
– – 0.08% 311
2017
Q4 		$1.5M Buy
+12,571
New +$1.53M 0.08% 299

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Redpoint Investment Management's ALXN Position: Q3 2021 in Review

Redpoint Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,684 shares — an estimated $1.23M sold.

Redpoint Investment Management first reported a position in ALXN in Q4 2017 and held it in 15 quarters. The position peaked at $2.92M in Q1 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Redpoint Investment Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Redpoint Investment Management sold 6,684 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.23M.
  • Redpoint Investment Management first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 15 quarters.
  • Redpoint Investment Management's Alexion Pharmaceuticals position peaked at $2.92M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Redpoint Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.